Castro-Malaspina H - Search Results

1

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.

Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, Littmann ER, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young JW, Peled J, Meagher RC, Jenq RR, van den Brink MRM, Giralt SA, Pamer EG, Xavier JB. Taur Y, et al. Sci Transl Med. 2018 Sep 26;10(460):eaap9489. doi: 10.1126/scitranslmed.aap9489. Sci Transl Med. 2018. PMID: 30257956 Free PMC article. Clinical Trial.

2

New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.

Collins NH, Carabasi MH, Bleau S, Jagiello C, Young JW, Castro-Malaspina H, Flomenberg N, Papadopoulos EB, Emanuel D, Gillio A, et al. Collins NH, et al. Prog Clin Biol Res. 1992;377:427-39. Prog Clin Biol Res. 1992. PMID: 1438441 No abstract available.

3

T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission.

Young JW, Papadopoulos EB, Cunningham I, Castro-Malaspina H, Flomenberg N, Carabasi MH, Gulati SC, Brochstein JA, Heller G, Black P, et al. Young JW, et al. Blood. 1992 Jun 15;79(12):3380-7. Blood. 1992. PMID: 1596577 Free article.

4

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.

Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, et al. Papadopoulos EB, et al. N Engl J Med. 1994 Apr 28;330(17):1185-91. doi: 10.1056/NEJM199404283301703. N Engl J Med. 1994. PMID: 8093146 Free article.

5

Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.

Michel G, Boulad F, Small TN, Black P, Heller G, Castro-Malaspina H, Childs BH, Gillio AP, Papadopoulos EB, Young JW, Kernan NA, O'Reilly RJ. Michel G, et al. Bone Marrow Transplant. 1997 Jul;20(2):107-12. doi: 10.1038/sj.bmt.1700857. Bone Marrow Transplant. 1997. PMID: 9244412

6

T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.

Papadopoulos EB, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F, Gillio AP, Kernan NA, Small TN, Szabolcs P, Taylor J, Yahalom J, Collins NH, Bleau SA, Black PM, Heller G, O'Reilly RJ, Young JW. Papadopoulos EB, et al. Blood. 1998 Feb 1;91(3):1083-90. Blood. 1998. PMID: 9446672 Free article.

7

Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.

Small TN, Papadopoulos EB, Boulad F, Black P, Castro-Malaspina H, Childs BH, Collins N, Gillio A, George D, Jakubowski A, Heller G, Fazzari M, Kernan N, MacKinnon S, Szabolcs P, Young JW, O'Reilly RJ. Small TN, et al. Blood. 1999 Jan 15;93(2):467-80. Blood. 1999. PMID: 9885208 Free article.

8

Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation.

Amsterdam A, Jakubowski A, Castro-Malaspina H, Baxi E, Kauff N, Krychman M, Stier E, Castiel M. Amsterdam A, et al. Bone Marrow Transplant. 2004 Aug;34(4):363-6. doi: 10.1038/sj.bmt.1704577. Bone Marrow Transplant. 2004. PMID: 15195079

9

Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants.

Jaffe D, Papadopoulos EB, Young JW, O'reilly RJ, Prockop S, Kernan NA, Jakubowski A, Boulad F, Perales MA, Castro-Malaspina H, Small TN. Jaffe D, et al. Blood. 2006 Oct 1;108(7):2470-5. doi: 10.1182/blood-2006-04-006981. Epub 2006 Jun 8. Blood. 2006. PMID: 16763208 Free PMC article.

10

Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.

Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G, Boulad F, Chiu M, Hsu K, Jakubowski A, Kernan NA, Perales MA, O'Reilly RJ, Papadopoulos EB. Small TN, et al. Biol Blood Marrow Transplant. 2007 Feb;13(2):235-44. doi: 10.1016/j.bbmt.2006.10.005. Biol Blood Marrow Transplant. 2007. PMID: 17241929 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters